​ ​ ​ ​
​

Gold medal for DZHK heart researcher

​
​
​
​
​
Overview
​

Professor Stefanie Dimmeler receives the ESC gold medal for her outstanding work as a cardiologist and cardiovascular researcher. It is considered the highest award of the European Society of Cardiology and is awarded annually.

​
​ ​
​
​

The Frankfurt heart researcher and director of the Institute of Cardiovascular Medicine at the Center for Molecular Medicine at Goethe University, Professor Stefanie Dimmeler, is honored with the Gold Medal of the European Society of Cardiology. Stefanie Dimmeler is a Principal Investigator at the DZHK and receives the award for her research that has contributed to a better understanding of cardiovascular diseases and the development of new treatment approaches.

​ ​

"I am very pleased with this award. The gold medal belongs to the entire team of students, staff, and colleagues who have worked together on the projects over many years," Professor Dimmeler said in thanking the students. The Gold Medal is awarded annually to two or three outstanding cardiologists or cardiovascular researchers worldwide as the European Society of Cardiology's highest award.

Professor Stefanie Dimmeler is the spokesperson of the Cardiopulmonary Institute, which is funded by the Excellence Strategy Program, and will become Chairman of the Board of Directors of the German Center for Cardiovascular Research (DZHK) starting January 2021. Her work has already been honored several times with top-class awards. Her research's primary focus is investigating repair possibilities and regeneration in the vascular system and the heart. In addition to the basic scientific explanation of processes, the development of therapeutic procedures for treating cardiovascular diseases is of particular importance. Most recently, she discovered that small non-coding RNAs regulate heart aging and heart function. She sees her scientific life-task in the long-term goal of deciphering the molecular mechanisms of cardiac repair to accelerate healing after a heart attack and cardiac insufficiency or to prevent their occurrence.

Scientific contact: Prof. Dr. Stefanie Dimmeler, Institute for Cardiovascular Regeneration, Goethe University Frankfurt, Office Management: herfurth(at)med.uni-frankfurt.de

Source: Press release Goethe University Frankfurt

Further press releases and news

    First microRNA therapy for the heart works in humans

    ​

    A group of researchers from Goethe University and University Hospital Frankfurt demonstrates that an inhibitor against microRNA-92a is effective in humans. The German Centre for Cardiovascular Research (DZHK) supported this clinical trial.

     ​
    ​ ​

    Stefanie Dimmeler elected new spokesperson of the DZHK

    ​

    Prof. Stefanie Dimmeler will start as the new spokesperson of the Board of Directors at the German Center for Cardiovascular Research (DZHK). She takes office in December 2020. Dimmeler succeeds Prof. Thomas Eschenhagen, who will retire from the Board of Directors at the end of...

     ​
    ​ ​

    More ACE2 in sick hearts

    ​

    ACE2 is a protein on the surface of cells and serves as an entry portal for the coronavirus SARS-CoV-2. A Frankfurt research group was able to show that ACE2 is significantly elevated in tissue samples from patients with cardiovascular diseases.

     ​
    ​ ​
​
​
​